Surface expression of CD70 has been associated with a higher risk of cancer malignancy and aberrant T-cell activation [13] in part due to CD70/CD27 interactions that can induce excessive infiltration of T cells and cause autoimmune disease [18,19]. This evidence concerns the gene CD27 and cancer.